Huisartspraktijk Broekman
- Address
- Plantageweg 3b, 3333 GZ Zwijndrecht, The Netherlands
Huisartspraktijk Broekman - Primary Care Research
Huisartspraktijk Broekman is a primary care practice engaged in clinical research focused on evaluating novel therapeutic interventions for infectious diseases in outpatient settings. The practice specializes in conducting community-based trials that assess treatment efficacy and safety for high-risk patients who can be managed outside of hospital environments.
- COVID-19 therapeutic interventions in high-risk outpatient populations
- Antiviral therapy efficacy and safety evaluation
- Prevention of disease progression and hospitalization in infectious diseases
The center contributes to advancing evidence-based treatment strategies by evaluating innovative compounds such as Bemnifosbuvir in real-world primary care settings. Their research focuses on critical clinical endpoints including all-cause hospitalization and mortality reduction, providing valuable data on early intervention approaches that can be implemented in general practice to improve patient outcomes and reduce healthcare burden.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 271 other sites in The Netherlands
Therapeutic Area Benchmark — The Netherlands
Select a therapeutic area to compare against other sites in The Netherlands.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: The Netherlands
Market Share
Country: The Netherlands
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Huisartspraktijk Broekman
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Bemnifosbuvir Hemisulfate Efficacy and Safety in High-Risk COVID-19 Outpatients: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial | Atea Pharmaceuticals Inc. | Phase III | Not Recruiting | Mar 2023 | May 2024 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Bemnifosbuvir Hemisulfate | 1 | Unknown | 2023-03-06 | 2023-03-06 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.